Advertisement

Topics

Protemix Corporation Limited Company Profile

21:23 EST 16th December 2018 | BioPortfolio

Protemix is a biopharmaceutical company dedicated to the discovery, development and commercialisation of novel treatments for cardiovascular disease, diabetes mellitus and other metabolic disorders and diseases.Protemix has developed an exciting pipeline of diabetes-related drugs, including one compound, Laszarin™, currently undergoing Phase IIb clinical trials and a number of promising pre-clinical drug candidates

Location

Level 28 IAG House151 Queen Street
PO Box 2165
Auckland
New Zealand

Contact

Phone: 64 9 303 5350
Fax: 64 9 303 5359
Email: info@protemix.com


News Articles [130 Associated News Articles listed on BioPortfolio]

Global and Asia Instant Adhesive Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global Instant Adhesive Market Status and Outlook 20182025 [Report Updated: 02082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Advanced Composites Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Global Polycarbonates Market Segmented by Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global polycarbonates market has been estimated at USD 13,720.95 million in 2017. The market is expected to register a CAGR of 5.46% during the forecast period, 2018 to 2023. Electrical and electr...

Global Polycarbonates Market Segmented by Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global polycarbonates market has been estimated at USD 13,720.95 million in 2017. The market is expected to register a CAGR of 5.46% during the forecast period, 2018 to 2023. Electrical and electr...

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation cl...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [261 Associated Companies listed on BioPortfolio]

Protemix Corporation Limited

Protemix is a biopharmaceutical company dedicated to the discovery, development and commercialisation of novel treatments for cardiovascular disease, diabetes mellitus and other metabolic disorders an...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Protemix Corporation Limited" on BioPortfolio

We have published hundreds of Protemix Corporation Limited news stories on BioPortfolio along with dozens of Protemix Corporation Limited Clinical Trials and PubMed Articles about Protemix Corporation Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Protemix Corporation Limited Companies in our database. You can also find out about relevant Protemix Corporation Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record